|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
177-181 Avenue Pierre Brossolette,Montrouge,France,FR
|
|
DBV Technologies is a global biopharmaceutical company that’s pioneering investigational epicutaneous immunotherapy (EPIT™) to potentially treat millions of people suffering from life-threatening food allergies and other immunological disorders. Starting with peanut, we are investigating food allergy treatments designed to potentially reduce the risk of unpredictable reactions due to accidental peanut exposure. We are actively working with leading immunologists and allergists to develop the EPIT technology platform to provide solutions across a range of conditions where unmet medical needs exist.
|
DBV Technologies Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
40%
|
The widely used DBV Technologies email format is {first}.{last} (e.g. [email protected]) with 40% adoption across the company.
To contact DBV Technologies customer service number in your country click here to find.
Daniel Tasse is the CEO of DBV Technologies. To contact Daniel Tasse email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.